Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Angiogenesis
100%
Interleukin-6
100%
Tumor Growth
100%
Interleukin-6 Receptor (IL-6R)
100%
Novel Peptide
100%
Vascular Endothelial Growth Factor
18%
Clinical Application
9%
Antiangiogenic Activity
9%
Dose Effect
9%
Human Cancer
9%
Cancer Cell Lines
9%
Severe Combined Immunodeficient Mice
9%
Cervical Cancer Cells
9%
Cervical Tumor
9%
Survival Signaling
9%
Targeted Therapeutics
9%
Small Peptides
9%
In Vivo Analysis
9%
Bioavailable
9%
Phage Display Library
9%
Library Screening
9%
Medicine and Dentistry
Angiogenesis
100%
Interleukin 6
100%
Tumor Progression
100%
Interleukin 6 Receptor
100%
Cytokine
57%
In Vitro
28%
Cancer Cell
14%
Cancer
14%
Antiangiogenic Activity
14%
Cervical Cancer
14%
Clinical Finding
14%
Vasculotropin
14%
Vasculotropin A
14%
SCID Mouse
14%
Phage Display
14%
Cancer Cell Line
14%
Biochemistry, Genetics and Molecular Biology
Tumor Progression
100%
Angiogenesis
100%
Interleukin 6
100%
Interleukin-6 Receptor
100%
Cytokine
57%
Cancer Cell
28%
Antiangiogenic Activity
14%
Vascular Endothelial Growth Factor A
14%
Vascular Endothelial Growth Factor
14%
SCID Mouse
14%
Phage Display
14%
Immunology and Microbiology
Peptides
100%
Interleukin 6
100%
Angiogenesis
100%
Interleukin-6 Receptor
100%
Cytokine
57%
Cancer Cell
14%
Antiangiogenic Activity
14%
Vasculotropin A
14%
Vasculotropin
14%
Cancer Cell Line
14%
SCID Mouse
14%
Phage Display
14%
Pharmacology, Toxicology and Pharmaceutical Science
Interleukin 6
100%
Tumor Growth
100%
Interleukin 6 Receptor
100%
Cytokine
57%
Malignant Neoplasm
14%
Bacteriophage
14%
Vasculotropin
14%
Antiangiogenic
14%
Uterine Cervix Cancer
14%
SCID Mouse
14%
Vasculotropin A
14%